70 likes | 84 Views
HIV Diagnostics Market size was USD 2.4 billion in 2015, and is forecast to grow at 9.5% CAGR up to 2023.<br><br>Get more details @ https://goo.gl/BcvGZY
E N D
HIV Diagnostics Market size worth $4.9bn by 2023 : Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024
KeyInsights from HIV Diagnostics Market : • Global HIV diagnostics market size is anticipated to reach USD 4.9 billion by 2023 from 2.4 billion in 2015, growing at an estimated CAGR of 9.5% from 2016 to 2023. • U.S. HIV diagnostics market share was the largest in North America, grabbing revenue of more than 75% in 2015. Regulatory support to prevent rising number of HIV/AIDS cases, and introduction of portable, convenient to use diagnostic tests is set to drive regional growth. • Antibody tests segment dominated the global HIV diagnostics market share in 2015, at more than USD 750 million in revenue, while the antibody test market was predominantly driven by HIV-1 screening tests market. • Germany was the revenue puller for Europe HIV diagnostics market, slated to showcase bringing in over 20% revenue in 2015, while UK is likely to witness relatively higher growth rate.
Continued... • Capital intensive nature of the industry, existing established players, and requirement of highly qualified personnel pose as challenges for new players to enter the market. • In APAC, China HIV diagnostics market is the fastest growing region, showcasing 10.9% CAGR during the forecast period, followed by Japan. • Roche, Abbott, Siemens, Qiagen, Sysmex and Hologic are some key companies for this industry.
U.S. HIV Diagnostics Market Size, by Product, 2012 - 2023 (USD Million)
Browse Full Market Research Report On HIV Diagnostics Market @ https://goo.gl/oeVBX7 Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/491
360° Analysis • Application Trends • Growing point of care (PoC) diagnostics industry should positively impact the HIV diagnostics tests market. Various factors such as minimal equipment requirement, quick diagnosis, robustness, cost–effectiveness, and convenience to use should drive the HIV point of care diagnostics market. Technological advancement in biochemical engineering for design of these tests in order to allow simultaneous detection and quantification of multiple targets with utilization of resource limited settings are anticipated to fuel market growth for HIV diagnostics. • Regional Trends • North America held a predominant chunk in the overall HIV diagnostics industry, valued at USD 946 million in 2015, rapid adoption of technologically advanced diagnostic solution service providers, and increasing demand for portable and point of care tests drives regional growth. • Competitive Market Share • Global HIV diagnostics market share is competitive, garnered by the presence of number of large firms, and various small players. Market players are undergoing collaborations, and mutually beneficial agreements with smaller market entities to enter untapped markets. Roche Diagnostics, Siemens Healthcare, Abbott Healthcare, and Alere, Inc are major players in the market.
Stay In Touch Website: www.gminsights.com Social Media: